Pharmaceutical standardization of saptarangyadi vati prepared by two methods and their comperative effect on MADHUMEHA(TYPE-2 DIABETIS MELLITUS)

Pharmaceutical standardization of saptarangyadi vati prepared by two methods and their comparative effect on MADHUMEHA(TYPE-2 DIABETIS MELLITUS)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/03/006769

Enrollment

Registered

2016-03-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- With sign and symptoms if disease otherwise healthy

Interventions

Intervention1: Saptarangyadi Ghana vati(method 1): Pharmacy Gujarat Ayurveda university anubhut Control Intervention1: saptrangyadi ghana vati(method 2): Prepared at pharmacy gujarat ayurved universit

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical symptoms of Type II D.M. (Madhumeha) will be selected from O.P.D. and I.P.D. of I.P.G.T. & R.A. Hospital, Jamnagar. Both the Genders having age between 30 to 70 years. Patients having Fasting glucose level >= 126 mg/dl and Post prandial glucose level >= 200 mg/dl.

Exclusion criteria

Exclusion criteria: Patients IDDM. Uncontrolled cases of Diabetes Patients having chronic complications of Diabetes Microvascular: Retinopathy, Neuropathy & Nephropathy. Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease. Other chronic debilitating diseases like Tuberculosis, STD etc.

Design outcomes

Primary

Measure	Time frame
will be generatedTimepoint: before and after treatment	—

Secondary

Measure	Time frame
will be generatedTimepoint: before and after treatment	—

Countries

India

Contacts

Public ContactMonika katiyar

IPGT RA jamnagar

Prajapati.pradeep1@gmail.com9978403323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026